PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 551,000
-6,000 (-1.08%)
Aug 1, 2025, 3:30 PM KST
Six Flags Entertainment Revenue
PharmaResearch had revenue of 116.91B KRW in the quarter ending March 31, 2025, with 56.47% growth. This brings the company's revenue in the last twelve months to 392.31B, up 39.97% year-over-year. In the year 2024, PharmaResearch had annual revenue of 350.12B with 34.14% growth.
Revenue (ttm)
392.31B
Revenue Growth
+39.97%
P/S Ratio
14.59
Revenue / Employee
959.19M
Employees
409
Market Cap
5,724.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 350.12B | 89.10B | 34.14% |
| Dec 31, 2023 | 261.01B | 66.25B | 34.02% |
| Dec 31, 2022 | 194.76B | 40.68B | 26.40% |
| Dec 31, 2021 | 154.08B | 45.34B | 41.69% |
| Dec 31, 2020 | 108.75B | 24.87B | 29.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| Peptron | 4.30B |
| HLB Co., Ltd. | 74.64B |
| LigaChem Biosciences | 146.42B |